BitMEX Debuts New Mobile Trading Experience With Intuitive Design and Controls 11-12-2025, 19:30

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma 17-11-2025, 18:00

VCI Global Powers Food Security Technology Company Agroz (AGRZ) to Nasdaq: Successful IPO Pricing and Trading Begins Today 1-10-2025, 19:08